115 related articles for article (PubMed ID: 32932545)
1. Antiphospholipid Antibodies Are Not Associated with Clinical Parameters or Prognostic Outcomes in Patients with Non-Hodgkin's Lymphoma.
Pal R; Varma S; Ahluwalia J; Prakash G
Hamostaseologie; 2020 Dec; 40(5):662-670. PubMed ID: 32932545
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma.
Genvresse I; Lüftner D; Späth-Schwalbe E; Buttgereit F
Eur J Haematol; 2002 Feb; 68(2):84-90. PubMed ID: 12038453
[TBL] [Abstract][Full Text] [Related]
4. [Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma].
Sciarra A; Stasi R; Stipa E; Masi M; Oliva F; Olivieri M; Perrotti A; Zaccari G; Amadori S; Papa G
Recenti Prog Med; 1995 Feb; 86(2):57-62. PubMed ID: 7754173
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma.
Stasi R; Stipa E; Masi M; Oliva F; Sciarra A; Perrotti A; Zaccari G; Papa G
Thromb Haemost; 1993 Oct; 70(4):568-72. PubMed ID: 8115979
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Clinical Significance of Antiphospholipid Antibodies in Hospitalized Patients With COVID-19 Infection.
Kahlon N; Shazadeh Safavi P; Abuhelwa Z; Sheikh T; Burmeister C; Doddi S; Assaly R; Barnett W
Cureus; 2022 Aug; 14(8):e27862. PubMed ID: 36110457
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.
Diz-Küçükkaya R; Hacihanefioğlu A; Yenerel M; Turgut M; Keskin H; Nalçaci M; Inanç M
Blood; 2001 Sep; 98(6):1760-4. PubMed ID: 11535509
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab.
Czuczman MS; Grillo-López AJ; Alkuzweny B; Weaver R; Larocca A; McLaughlin P
Leuk Lymphoma; 2006 Sep; 47(9):1830-40. PubMed ID: 17064996
[TBL] [Abstract][Full Text] [Related]
9. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
[TBL] [Abstract][Full Text] [Related]
10. Subtypes of Antiphospholipid Antibodies in Neurologic Disorders: An Observational Study.
Sahebari M; Rastin M; Boostani R; Forughipour M; Hashemzadeh K; Sadeghi SH
Curr Rheumatol Rev; 2019; 15(1):59-66. PubMed ID: 29756580
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies in children without and in adults with and without thrombophilia.
Siemens HJ; Gutsche S; Brückner S; Bucsky P; Katus HA
Thromb Res; 2000 May; 98(4):241-7. PubMed ID: 10822070
[TBL] [Abstract][Full Text] [Related]
12. Higher Incidence of Pulmonary Hypertension in Antiphospholipid Antibody Positive Lupus.
Ware D; Sharma V; Kalekar L; Kamble A; Mahajan A; Gokhale Y
J Assoc Physicians India; 2015 Apr; 63(4):17-20. PubMed ID: 26591164
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
15. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.
Stelitano C; Baldini L; Pieresca C; Callea V; Angrilli F; Clò V; Partesotti G; Merli F; Cavanna L; Morabito F; Federico M; Brugiatelli M; Silingardi V
Haematologica; 2000 Feb; 85(2):154-9. PubMed ID: 10681722
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and treatment outcome of 36 cases with non-Hodgkin's lymphoma arising from mediastinum in children].
Tang YJ; Tang JY; Pan C; Xue HL; Chen J; Shen SH; Dong L; Zhou M; Wang YP; Gu LJ; Jiang H; Ye QD
Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):687-90. PubMed ID: 20021793
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
18. Elderly patients with non-Hodgkin's lymphoma: population-based results in The Netherlands.
Maartense E; Hermans J; Kluin-Nelemans JC; Kluin PM; Van Deijk WA; Snijder S; Wijermans PW; Noordijk EM
Ann Oncol; 1998 Nov; 9(11):1219-27. PubMed ID: 9862053
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma].
Song LN; Cen XN; Ou JP; Liang ZY; Qiu ZX; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Yin Y; Sun YH; Liu W; Wang Q; Wang LH; Wang Y; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038
[TBL] [Abstract][Full Text] [Related]
20. Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
Spaepen K; Stroobants S; Dupont P; Vandenberghe P; Thomas J; de Groot T; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G
Ann Oncol; 2002 Sep; 13(9):1356-63. PubMed ID: 12196360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
